News
20hon MSN
Eli Lilly Stock Is On Track for Its Worst Performance Since 2008. Should Investors Be Worried?
Eli Lilly › Eli Lilly (NYSE: LLY) has been a terrific stock to own over the past 15 years; it has consistently outperformed ...
Early trials of the drug, retatrutide, have already shown it can help people shed a quarter of their body weight in under a ...
Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.
Criminals were caught trying to import the likes of Wegovy and Mounjaro in 'large-scale' smuggling operations.
19h
Zacks.com on MSNIs Orforglipron Pill Setback End of the Road for LLY's Obesity Plans?
Lilly's obesity pill orforglipron disappointed with lower weight loss, but its broad late-stage pipeline keeps growth hopes ...
BRITAIN has gone fat jab crazy — with sales of Wegovy soaring by more than 2,000 per cent in the past month. Dieters are ...
A week on from increases in the cost of Eli Lilly’s weight loss drug Mounjaro (tirzepatide), weight loss medication provider ...
CheqUp said it had experienced a spike in interest from consumers wanting to switch or begin taking the medication.
5hon MSNOpinion
OPINION - The soaring price of weight loss drugs could derail the NHS's obesity plan - unless they take this action
From 1 September, the list price for the most popular and effective weight loss injection (Mounjaro) in the UK will rise by ...
A MAJOR high street pharmacy has stopped selling Mounjaro amid a nationwide shortage of the popular fat jab. It comes just days after The Sun revealed the price of the ‘King Kong’ injection would ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results